Tenex Health received FDA 510(k) clearance to market TX®-Bone ultrasonic technology.
TX-Bone is employed through a small incision with an ultrasound or palpation guided technique to perform selective cutting and debriding of pain-generating bone and calcific tissue. Applications include rotator cuff, triceps, the gluteus/trochanteric region, Achilles tendon insertion, Haglund’s deformity and plantar fascia insertion spurs.
To date, TX technology has successfully been used in over 90,000 cases.
Source: Tenex Health
Tenex Health received FDA 510(k) clearance to market TX®-Bone ultrasonic technology.
TX-Bone is employed through a small incision with an ultrasound or palpation guided technique to perform selective cutting and debriding of pain-generating bone and calcific tissue. Applications include rotator cuff, triceps, the gluteus/trochanteric region,...
Tenex Health received FDA 510(k) clearance to market TX®-Bone ultrasonic technology.
TX-Bone is employed through a small incision with an ultrasound or palpation guided technique to perform selective cutting and debriding of pain-generating bone and calcific tissue. Applications include rotator cuff, triceps, the gluteus/trochanteric region, Achilles tendon insertion, Haglund’s deformity and plantar fascia insertion spurs.
To date, TX technology has successfully been used in over 90,000 cases.
Source: Tenex Health
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.